MeD-Scan
A proprietary Multiplex qPCR for the detection of cervical AND all other anogenital cancers

Validation on Biopsies (n=260)
- Detects all anogenital cancers, as well as skin and colon cancers
Validation on Cervical Swabs
Cervical cancer screening (n=275)
- Sensitivity for CIN3+ of 93,8%
- Specificity for ≤CIN1 of 78,8%
Case control study (n=160)
- Detects all cervical and endometrium cancers from cervical swabs